Ligand · CK2
CK2 · 4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine
CK2, 4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine (C9 H10 N4 S, 206.3 g/mol), in the MolNFT structures on GenesisL1: bound in 6 records (3 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most…
- Component
- CK2
- Formula
- C9 H10 N4 S
- Class
- ligand
- Structures
- 6
- PDB entries
- 3
Binding sites
CK2 in 6 structures; the first of them:
- 1PXJ · HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR… · CK2 A500 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 9 more
- 2C5O · Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug… · CK2 A1297 · binds ILE10, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64, PHE80 and 6 more
- 4FKL · Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor · CK2 A300 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 9 more
- 1PXJ · Human cyclin dependent kinase 2 complexed with the inhibitor… · CK2 A500 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 9 more
- 2C5O · Differential binding of inhibitors to active and inactive CDK2 provides insights for drug… · CK2 A1297 · binds ILE10, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64, PHE80 and 6 more
- 4FKL · Crystal structure of the CDK2 in complex with thiazolylpyrimidine inhibitor · CK2 A300 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 9 more
Residues it binds most
ALA 8, GLU 8, LEU 8, PHE 8, VAL 8, GLY 6, ASP 8, ILE 8, LYS 8, GLN 6 (residue and the binding sites it lines).
Found with
- ACE · Acetyl group
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.